Plunkett Research Online: ACADIA Pharmaceuticals Inc

ACADIA PHARMACEUTICALS INC (ACAD:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. ACADIA currently is developing a portfolio consisting of its four most advanced product candidates including pim.....



ACADIA Pharmaceuticals Inc
Ticker: ACAD
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 858 558-2871
Fax: 858 558-2872
Address: 3611 Valley Centre Drive
Suite 300
San Diego, CA 92130 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
Stephen DavisCEO/Director/President
Todd YoungCFO/Chief Accounting Officer
See More
ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. ACADIA currently is developing a portfolio consisting of its four most advanced product candidates including pim.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor: Cooley LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: